A Guide for Pain Management in Developing Nations: The Diagnosis and Assessment of Pain in Cancer Patients
- Authors
-
-
Joseph V. Pergolizzi
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA 2Department of Anesthesiology, Georgetown University School of Medicine, Washington, D.C., USA 3Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA -
Gianpietro Zampogna
NEMA Research, Naples, Florida, USA -
Robert Taylor
NEMA Research, Naples, Florida, USA -
Marixa Guerrero
Medical Director of Instituto de Ortopedia Roosevelt, Bogota, Colombia -
Juan Quillermo Santacruz
Palliativist of Fundacion Santa fe, Bogota, Colombia -
Robert B. Raffa
Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania, USA
-
- Keywords:
- Cancer pain, malignant pain, opioid analgesia, opioids, undertreatment of cancer pain, assessment of cancer pain.
- Abstract
-
The fundamental approach to cancer patients with pain is to identify the pain sites, and describe, quantify, and categorize the pain by type at each site. There are many validated tools to serve the clinician in these efforts, particularly for pain assessment. Multimechanistic pain syndromes are common in cancer patients. Cancer patients may experience nociceptive pain. They may also experience neuropathic pain due to chemotherapy-induced or cancer-related nerve damage. Analgesic choices must be guided by the pain mechanisms, nature, and severity of the pain, comorbid conditions, and patient characteristics. Long-acting opioid analgesics or fixed-clock dosing can eliminate end-of-dose analgesic gaps. The potential for opioid abuse is an important public health challenge but one that should not undermine the appropriate treatment of moderate to severe cancer pain. Abuse-deterrent opioid formulations can be useful. Care is needed for special populations of cancer patients dealing with pain, such as geriatric, pediatric, or obese patients. While morphine has long been the gold standard of oral opioid products, recent clinical trials suggest that oral hydrocodone and oral oxycodone may offer advantages over oral morphine. Patient adherence is crucial for adequate analgesia and patient education can promote adherence and manage expectations.
- Downloads
-
Download data is not yet available.
- Downloads
- Published
- 14-01-2016
- Issue
- Vol. 5 No. 1 (2016)
- Section
- Articles
How to Cite
Similar Articles
- Anupam Sarma, Debabrata Barmon, J.D. Sharma, Amal Chandra Kataki, Chidananda Bhuyan, Primary Non-Hodgkin's Lymphoma of the Uterine Cervix: Report of Three Cases with Immunohistochemical Study , Journal of Cancer Research Updates: Vol. 1 No. 1 (2012)
- Marwa Aboalsoud, Zeinab Fathy Abdallah, Rabab A. Moussa, Eman E. Farghal, Asmaa Mohamed Elkady, Bevacizumab in Advanced High Grade Serous Ovarian Cancer: The Impact of BRCA Mutation Status , Journal of Cancer Research Updates: Vol. 15 No. 1 (2026)
- Mian Chen, Inorganic Nanoplatforms for Simultaneous Cancer Imaging and Therapy: Status and Challenges , Journal of Cancer Research Updates: Vol. 6 No. 1 (2017)
- Pankaj Deka, Amal Chandra Kataki, Debabrata Barmon, Bibhuti Bhushan Borthakur, Sushruta Shrivastava, Peritoneal Carcinomatosis with Displaced IUCD , Journal of Cancer Research Updates: Vol. 1 No. 2 (2012)
- Raafat S. Alameddine, Nagi S. El Saghir, Elias Elias, Ahmad Saleh, Fady B. Geara, Sally Temraz, Ali Shamseddine, Effects of Nodal Status and Extent of Surgery on Survival in Triple Negative Breast Cancer , Journal of Cancer Research Updates: Vol. 2 No. 4 (2013)
- Hirendra Banerjee, Jamel Joyner, Monet Stevenson, William Kahan, Christopher Krauss, Sasha Hodges, Eduardo Santos, Myla Worthington, Jeffferey Rousch, Gloria Payne, Vinod Manglik, Narendra Banerjee, Brianna Morris, Dayton Bell, Santosh Mandal, Short Communication: Studying the Role of Smart Flare Gold Nano Particles in Studying Micro RNA and Oncogene Differential Expression in Prostate Cancer Cell Lines , Journal of Cancer Research Updates: Vol. 6 No. 2 (2017)
- Fatma Gharib, Rana Ali El Falah, Amr S. Ghobara, Sherehan Moeness ElShishtawy, Radwa A. Awad, Hypofractionated Versus Conventional Fractionated Radiotherapy for Patients with Triple Negative Breast Cancer: A Single Institution Randomized Trial , Journal of Cancer Research Updates: Vol. 14 (2025)
- Kenichi Suda, Simon Ito, Hiroshi Mizuuchi, Yoshihiko Maehara, Yasushi Yatabe, Tetsuya Mitsudomi, EGFR Tyrosine Kinase Inhibitors Prolong Overall Survival in EGFR Mutated Non-Small-Cell Lung Cancer Patients with Postsurgical Recurrence , Journal of Cancer Research Updates: Vol. 1 No. 1 (2012)
- Ladislav Novotny, Samuel B. Kombian , Vanadium: Possible Use in Cancer Chemoprevention and Therapy , Journal of Cancer Research Updates: Vol. 3 No. 2 (2014)
- Atish Patel, Hui Zhang, Deshen Wang, Dong-Hua Yang, Sanjay Dholakiya, Zhe-Sheng Chen1, Pharmacotherapeutic Options for Philadelphia Chromosome-Positive CML , Journal of Cancer Research Updates: Vol. 7 No. 2 (2018)
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Joseph V. Pergolizzi Jr., Robert B. Raffa, Emilio Esteban Gonzalez, Jo Ann LeQuang, A Guide for Cancer Pain Management in Latin America , Journal of Cancer Research Updates: Vol. 6 No. 4 (2017)
- Joseph V. Pergolizzi Jr, Robert Taylor Jr, Gianpietro Zampogna, Fuat H. Demirelli, Serdar Erdine, Robert B. Raffa, Oxycodone Immediate Release for Cancer Pain Management in Turkey: Maximizing Value in Opioid Analgesics , Journal of Cancer Research Updates: Vol. 3 No. 4 (2014)